Peptide RX

back to claim graph

proof receipt / target

GLP-1R

Glucagon-like peptide-1 receptor

grade B status metabolic receipt 4de15d654b2f proof 33%

what this node claims

GLP-1R

Glucagon-like peptide-1 receptor

Open source surface

vertical proof spine

  1. 01 GLP-1R target / grade B / 70% 1 debt
  2. 02 Effect design run idea / grade C / 47% 1 debt
  3. 03 GLP1R WT fold / grade B / 66% 2 debt

evidence / risk instrument

43%
thin proof
structure evidence gates risk export lineage 43
low debt pressure 30%
28%structuredebt
pLDDT pending
78%evidenceusable
grade B
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine

proof completeness

33% missing alphafold_metric, candidate, finding, export
  1. 01 target
  2. 02 fold
  3. 03 alphafold metric
  4. 04 candidate
  5. 05 finding
  6. 06 export

Metrics and receipt inputs

binding partners
    context annotations
    0
    family
    GPCR_class_B
    functional sites
      gene symbol
      GLP1R
      go terms
        uniprot
        P43220

        AlphaFold metrics visual

        Confident backbone model

        81.5

        463 residues / min 27.03 / max 98.25 / source alphafold db

        PAE matrix for linked target
        Very high 47.1% 218 residues / >=90
        Confident 35.6% 165 residues / 70-89
        Low 5.8% 27 residues / 50-69
        Very low 11.4% 53 residues / <50

        usable fold context with explicit model-confidence limits

        Near-complete coverage / observed 463 of 463 residues.

        • residues 432-463 / mean 43.36
        • residues 1-30 / mean 39.91
        • residues 130-137 / mean 55.76
        • residues 370-376 / mean 59.89
        proof debt register

        Visible limits, not hidden cleanup.

        30%

        Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.

        medium missing functional-site annotations link target annotation, GO term, or binding-site context
        low computational-only status add independent evidence, challenge result, or witness review before strengthening
        medium no candidate yet leave visible until a stronger public receipt resolves it
        medium no candidate yet leave visible until a stronger public receipt resolves it

        weakness and challenge edges

        What would stop this from becoming stronger.

        debt severity export claim strength next proof needed
        missing functional-site annotations medium visible weakens link target annotation, GO term, or binding-site context
        computational-only status low visible watch add independent evidence, challenge result, or witness review before strengthening
        no candidate yet medium visible weakens leave visible until a stronger public receipt resolves it
        no candidate yet medium visible weakens leave visible until a stronger public receipt resolves it

        what supports it

        effect run matched target idea:effect-run:6d89df5a-7637-49ff-b4c4-0237bd06d090 -> target:c6c265ea-7550-4914-a2ee-b295e4a1e476 targets / C / 0.52

        what it supports

        target has structure prediction target:c6c265ea-7550-4914-a2ee-b295e4a1e476 -> fold:af1fb866-d507-4048-9c36-ba5b07a5d376 folds_to / B / 0.815

        Research-use boundary

        This receipt describes public computational research state. It does not expose raw candidate sequences and does not make a clinical claim.